H

Hyphens Pharma International Ltd
SGX:1J5

Watchlist Manager
Hyphens Pharma International Ltd
SGX:1J5
Watchlist
Price: 0.285 SGD -1.72% Market Closed
Market Cap: 88.1m SGD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+25%
Revenue
Forecast
+8%
Operating Income
Forecast
+8%
Net Income
Forecast
+12%

Wall Street
Price Targets

1J5 Price Targets Summary
Hyphens Pharma International Ltd

Wall Street analysts forecast 1J5 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 1J5 is 0.357 SGD with a low forecast of 0.354 SGD and a high forecast of 0.368 SGD.

1J5 Lowest Forecast
Wall Street Target
0.354 SGD
24% Upside
1J5 Average Forecast
Wall Street Target
0.357 SGD
25% Upside
1J5 Highest Forecast
Wall Street Target
0.368 SGD
29% Upside
Lowest
Price Target
0.354 SGD
24% Upside
Average
Price Target
0.357 SGD
25% Upside
Highest
Price Target
0.368 SGD
29% Upside
Hyphens Pharma International Ltd Competitors:
Price Targets
002603
Shijiazhuang Yiling Pharmaceutical Co Ltd
45% Upside
600535
Tasly Pharmaceutical Group Co Ltd
15% Upside
F
FAE
Faes Farma SA
6% Upside
I
IMP
Imexpharm Corp
10% Downside
002603
Shijiazhuang Yiling Pharmaceutical Co Ltd
45% Upside
600535
Tasly Pharmaceutical Group Co Ltd
15% Upside
F
FAE
Faes Farma SA
6% Upside
I
IMP
Imexpharm Corp
10% Downside
HIKAL
Hikal Ltd
8% Upside
C
570
China Traditional Chinese Medicine Holdings Co Ltd
18% Downside
C
300765
CSPC Innovation Pharmaceutical Co Ltd
16% Upside

Revenue
Forecast

Revenue Estimate
Hyphens Pharma International Ltd

For the last 7 years the compound annual growth rate for Hyphens Pharma International Ltd's revenue is 8%. The projected CAGR for the next 3 years is 8%.

8%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Hyphens Pharma International Ltd

For the last 7 years the compound annual growth rate for Hyphens Pharma International Ltd's operating income is 8%. The projected CAGR for the next 4 years is 7%.

8%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Hyphens Pharma International Ltd

For the last 7 years the compound annual growth rate for Hyphens Pharma International Ltd's net income is 7%. The projected CAGR for the next 3 years is 12%.

7%
Past Growth
12%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

See Also

Summary
1J5 intrinsic value, competitors valuation, and company profile.
DCF Valuation
1J5 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
1J5 stock valuation using valuation multiples.
Wall Street Estimates
1J5 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
1J5 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 1J5's stock price target?
Price Target
0.357 SGD

According to Wall Street analysts, the average 1-year price target for 1J5 is 0.357 SGD with a low forecast of 0.354 SGD and a high forecast of 0.368 SGD.

What is Hyphens Pharma International Ltd's Revenue forecast?
Projected CAGR
8%

For the last 7 years the compound annual growth rate for Hyphens Pharma International Ltd's revenue is 8%. The projected CAGR for the next 3 years is 8%.

What is Hyphens Pharma International Ltd's Operating Income forecast?
Projected CAGR
7%

For the last 7 years the compound annual growth rate for Hyphens Pharma International Ltd's operating income is 8%. The projected CAGR for the next 4 years is 7%.

What is Hyphens Pharma International Ltd's Net Income forecast?
Projected CAGR
12%

For the last 7 years the compound annual growth rate for Hyphens Pharma International Ltd's net income is 7%. The projected CAGR for the next 3 years is 12%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 240,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.